As of April 18, 2025, Oncodesign Precision Medicine Opm SA (ALOPM.PA) has a market cap of $15.694 million USD. According to our data, Oncodesign Precision Medicine Opm SA is ranked No.8649 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $15.69 M |
6.16%
|
Dec 31, 2024 | $14.78 M |
-60.55%
|
Dec 29, 2023 | $37.48 M |
6.47%
|
Dec 30, 2022 | $35.20 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$9.97 B |
-0.000 M
|
![]() USA
|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
![]() Canada
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.83 B |
-0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.83 B |
-0.000 M
|
![]() USA
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
-0.670 M
|
![]() USA
|
Market Cap | = | ALOPM.PA Stock Price | * | ALOPM.PA Shares Outstanding |
= | $0.86 | * | 18.17 M | |
= | $15.69 M |